SHS is set to raise another 600 billion dong through two private bond placements, underscoring how quickly debt refinancing can become a central part of a financial company’s capital strategy.
SHS Plans 600 Billion Dong Bond Refinancing

The move matters because it is not growth capital, but a refinancing exercise: the proceeds are earmarked to restructure borrowings coming due in October 2026. In other words, SHS is buying time. For investors, that usually means the key question is not whether the company can raise funds once, but whether it can keep doing so on terms that preserve earnings power and balance-sheet flexibility.
The two planned issues, both expected in the fourth quarter of 2026, would each carry a one-year maturity and a fixed coupon of 10.5% a year. They are non-convertible, unsecured and without warrants, which makes them straightforward debt but also leaves investors exposed to the company’s credit profile rather than any equity upside.
One tranche would comprise 2,000 bonds, or 200 billion dong, to refinance three obligations due in October. The second would total 4,000 bonds, or 400 billion dong, to roll over other debt maturing in the same month. SHS has already raised 575 billion dong in two earlier bond deals this year, suggesting a steady reliance on the market to manage upcoming liabilities.
That matters for the broader story because SHS is also leaning on other capital actions. The company has approved a 45 million-share bonus issue, a separate 15 million-share offering to fund margin lending, and a cash dividend of 5% of par value, worth nearly 450 billion dong. For a securities firm, that mix says a lot: it wants to reward shareholders and expand brokerage activities, but it must first make sure the liability side is funded.
For long-term investors, the real issue is sustainability. High-coupon debt can work if asset growth, lending income and trading activity cover the cost of capital. If not, refinancing simply pushes the problem forward and can compress returns. SHS shares closed at 12,700 dong on Oct. 5, giving the market a chance to decide whether the company’s repeated funding plan looks prudent or burdensome.
In the near term, the bond sale should help SHS avoid a liquidity squeeze and preserve operating room. Over the longer haul, investors will want to watch whether this is a temporary bridge to stronger earnings or the beginning of a more expensive funding cycle.
| Entity | Gains | Losses |
|---|---|---|
| SHS | ▲Refinance debt due | ▼Higher interest burden |
| Bond buyers | ▲10.5% coupon income | ▼Credit and refinancing risk |
| Existing shareholders | ▲Avoid near-term liquidity stress | ▼Potential dilution and cash use |
| Competing brokers | ▲Less funding strain if stronger balance sheet | ▼SHS may regain lending capacity |


